An Open-Label Safety Study of A-101 Solution

Summary

This is an open-label safety study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face.

Timeline

Start

2016-01

Primary completion

2016-10

Completion

2016-10

Drugs

Indications